Literature DB >> 2015851

Cytoskeleton in TFG-beta- and bFGF-modulated endothelial monolayer repair.

B L Coomber1.   

Abstract

Endothelial cell proliferation and migration in vitro is depressed by transforming growth factor beta (TFG-beta) and enhanced by basic fibroblast growth factor (bFGF) treatment. This study examines interactions between cytoskeletal changes and cell proliferation in regenerating endothelial monolayers treated with bFGF, TFG-beta, and both factors. As previously described by others, monolayer regeneration is enhanced by bFGF and reduced by TFG-beta. Endothelial cell morphology is altered by TFG-beta treatment. Cells lose their cobblestone appearance and assume a pleomorphic shape. Actin microfilament staining is modified in both intact and regenerating TFG-beta-treated monolayers as well. There is a loss of dense peripheral band staining and an enhancement in staining intensity of cytoplasmic stress fibers. No such alterations are seen in bFGF-treated cultures. Cell proliferation at the wound edge, as indicated by bromodeoxyuridine incorporation, is inhibited by TGF-beta. Although monolayer repair is modulated by growth factor treatment, centrosome reorientation and microtubule staining patterns are not altered by either factor. Thus these factors appear to have effects on a mechanism(s) other than centrosome reorientation which may be involved in repair of denuded endothelial monolayers.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2015851     DOI: 10.1016/0014-4827(91)90127-g

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  2 in total

1.  Transforming growth factor-beta1 effects on endothelial monolayer permeability involve focal adhesion kinase/Src.

Authors:  Young H Lee; Usamah S Kayyali; Anne Marie Sousa; Thomas Rajan; Robert J Lechleider; Regina M Day
Journal:  Am J Respir Cell Mol Biol       Date:  2007-06-21       Impact factor: 6.914

2.  Suppression of matrix metalloproteinase-2-mediated cell invasion in U87MG, human glioma cells by anti-microtubule agent: in vitro study.

Authors:  D Yoshida; J M Piepmeier; T Bergenheim; R Henriksson; A Teramoto
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.